Nutrition and the Prevention and Treatment of Cancer: Association of Cytochrome P450 CYP1B1 With the Role of Fruit and Fruit Extracts

被引:15
作者
Ware, William R. [1 ]
机构
[1] Univ Western Ontario, Fac Sci, London, ON, Canada
关键词
CYP1B1; fruit extracts; cytotoxins; phytochemicals; natural cancer therapy; TUMOR-SPECIFIC EXPRESSION; PROSTATE CARCINOMA; AGENT RESVERATROL; 1B1; METABOLISM; P450CYP1B1; ENZYMES; P4501B1; TOXICITY; TARGET;
D O I
10.1177/1534735408328573
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Recommendations for a healthy or prudent diet include a large number of daily servings of fruits and vegetables, and these 2 classes of food are widely believed to assist in cancer prevention. One potential mechanism that is rarely mentioned in nutritional studies involves the cytochrome P450 enzyme CYP1B1, which appears to have the unique properties of being a universal cancer marker overexpressed in cancer cells and having the capability of converting various phytochemicals and synthetic chemicals into substances cytotoxic to these cells. Although these particular features of CYP1B1 have not gone unnoticed, there has been relatively little research aimed at exploiting them. Furthermore, therapeutic and preventive strategies currently being considered based on vaccines against the enzyme or inhibition without the generation of cytotoxins can be questioned because they do not take advantage of the unique properties of this enzyme. In addition, a few relevant case histories have been published that use specially designed fruit extracts containing substrates with demonstrated cytotoxic metabolic products, and these reports provide an initial confirmation of the potential of exploiting the unusual properties of this enzyme for cancer therapy.
引用
收藏
页码:22 / 28
页数:7
相关论文
共 42 条
[1]
Cytochrome P450 1B1 expression in glial cell tumors:: An immunotherapeutic target [J].
Barnett, Julia A. ;
Urbauer, Diana L. ;
Murray, Graeme I. ;
Fuller, Gregory N. ;
Heimberger, Amy B. .
CLINICAL CANCER RESEARCH, 2007, 13 (12) :3559-3567
[2]
Cytochrome P4501B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation [J].
Belous, Alexandra R. ;
Hachey, David L. ;
Dawling, Sheila ;
Roodi, Nady ;
Parl, Fritz F. .
CANCER RESEARCH, 2007, 67 (02) :812-817
[3]
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development [J].
Bruno, Robert D. ;
Njar, Vincent C. O. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (15) :5047-5060
[4]
Target validation of cytochrome P450CYP1B1 in prostate carcinoma with protein expression in associated hyperplastic and premalignant tissue [J].
Carnell, DM ;
Smith, RE ;
Daley, FM ;
Barber, PR ;
Hoskin, PJ ;
Wilson, GD ;
Murray, GI ;
Everett, SA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (02) :500-509
[5]
Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer [J].
Chang, BL ;
Zheng, SL ;
Isaacs, SD ;
Turner, AR ;
Hawkins, GA ;
Wiley, KE ;
Bleecker, ER ;
Walsh, PC ;
Meyers, DA ;
Isaacs, WB ;
Xu, J .
BRITISH JOURNAL OF CANCER, 2003, 89 (08) :1524-1529
[6]
Chang TKH, 2001, J PHARMACOL EXP THER, V299, P874
[7]
Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumours [J].
Cheung, YL ;
Kerr, AC ;
McFadyen, MCE ;
Melvin, WT ;
Murray, GI .
CANCER LETTERS, 1999, 139 (02) :199-205
[8]
Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia -: A population-based cohort study in Sweden [J].
Chokkalingam, AP ;
Nyrén, O ;
Johansson, JE ;
Gridley, G ;
McLaughlin, JK ;
Adami, HO ;
Hsing, AW .
CANCER, 2003, 98 (08) :1727-1734
[9]
Discovery of cytochrome p450 1B1 inhibitors as new promising anti-cancer agents [J].
Chun, YJ ;
Kim, SH .
MEDICINAL RESEARCH REVIEWS, 2003, 23 (06) :657-668
[10]
Selected phenolic compounds in cultivated plants: Ecologic functions, health implications, and modulation by pesticides [J].
Daniel, O ;
Meier, MS ;
Schlatter, J ;
Frischknecht, P .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 :109-114